✦ LIBER ✦

PCN81 COST-EFFECTIVENESS ANALYSIS OF THREE STRATEGIES OF ERLOTINIB TREATMENT IN NON0-SMALL-CELL LUNG CANCER:A PROSPECTIVE MULTICENTRIC FRENCH STUDY (ERMETIC)

✍ Scribed by I Borget; J Cadranel; A Mauguen; B Coudert; E Dansin; S Friard; C Daniel; E Quoix; J Madelaine; A Madroszyk; F Morin; JP Pignon; C Chouaid

Book ID: 118614171
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 77 KB
Volume: 13
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(11)71976-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN97 COST EFFECTIVENESS OF ERLOTINIB TR

PCN97 COST EFFECTIVENESS OF ERLOTINIB TREATMENT GIVEN BY A CLINICALLY BASED APPROACH AND AN EGFR/KRAS TESTING-GUIDED APPROACH ADVANCED IN NON SMALL-CELL LUNG CANCER: A PROSPECTIVE MULTICENTRIC FRENCH STUDY (ERMETIC)

✍ I Borget; J Cadranel; JP Pignon; G Danton; B Coudert; E Dansin; S Friard; C Dani 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCN77 COST-EFFECTIVENESS ANALYSIS OF ERL

PCN77 COST-EFFECTIVENESS ANALYSIS OF ERLOTINIB IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN ROMANIA

✍ TE Ciuleanu; M Dediu; LN Minea; S Baculea; M Szkultecka-Debek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCN25 COST-EFFECTIVENESS ANALYSIS OF ERL

PCN25 COST-EFFECTIVENESS ANALYSIS OF ERLOTINIB VERSUS DOCETAXEL AS A SECOND- OR THIRD-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN KOREA

✍ Kim, YG; Lee, EK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCN90 Cost-Effectiveness Analysis of Erl

PCN90 Cost-Effectiveness Analysis of Erlotinib Versus Docetaxel, Pemetrexed for Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer in Russia

✍ Nguyen, T.T.T.; Yagudina, R.; Kulikov, A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCN84 COST-EFFECTIVENESS OF ERLOTINIB IN

PCN84 COST-EFFECTIVENESS OF ERLOTINIB IN FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN FIT ELDERLY PATIENTS: AN ECONOMICAL ANALYSIS OF A PROSPECTIVE PHASE 2 STUDY (GFPC 0504)

✍ C Chouaid; H Lecaer; J Crequit; I Monnet; S Chouabe; C Locher; D Paillotin; JB A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCN79 Cost Effectiveness of Erlotinib in

PCN79 Cost Effectiveness of Erlotinib in First Line Treatment of Advanced Non Small Cell Lung Cancer (NSCLC) in Vulnerable Elderly Patients: An Economical Analysis of a prospective Phase 2 Study (GFPC 0505)

✍ Chouaid, C.; Le Caer, H.; Corre, R.; Crequit, J.; Jullian, H.; Falchero, L.; Duj 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB